News | April 20, 2015

Joan Lunden among advocates calling for increased screening access, parity of insurance coverage for treatment options

Komen, advocates, breast cancer, Congress, Joan Lunden, Brinker, Salerno

Nancy G. Brinker (left), founder and chair of global strategy for Susan G. Komen breast cancer survivor and former \"Good Morning America\" host Joan Lunden (center) and Komen President and CEO Judy Salerno, M.D., (right) at the Komen Advocacy Summit. Photo courtesy of Business Wire.


April 20, 2015 — Members of the Susan G. Komen Foundation took to the nation’s capitol April 16 to advocate for the importance of access to cancer screening programs. The group also called on policy makers to ensure parity of insurance coverage between oral chemotherapy and traditional IV treatments.   

Among the group was breast cancer survivor and former “Good Morning America” host Joan Lunden. Lunden, who was diagnosed with triple negative breast cancer last summer, met with members of her home state of Connecticut — including U.S. Sen. Chris Murphy and Rep. Rosa DeLauro — to talk about her experience with breast cancer. She stressed the importance of women knowing about breast density, and pushing to have a secondary screening if they have dense breast tissue, an action that found her breast cancer after receiving a clean mammogram.

Komen advocates from its community Affiliate Network visited 360 offices in both the House and Senate to push for maintaining the government’s commitment to vital safety net programs, such as the National Breast and Cervical Cancer Early Detection Program. They also discussed the importance of ensuring parity between the way insurance covers oral chemotherapy, which often is governed by prescription drug benefit rules, and traditional IV treatments, which often have lower co-pays.

“Everything we do is aimed at ending this disease, and helping the millions of people who need us, every single day,” said Judith A. Salerno, M.D., M.S., Komen’s president and CEO, noting that Komen is also encouraging increases for biomedical research funding. “The fact is that biomedical research funding has dropped by 25 percent in real dollar terms over the past 10 years and we run the risk that medical research will stall. We urge the federal government to increase this important funding.”

The Summit kicked off with a dinner that featured remarks from Lunden, who discussed how her diagnosis has inspired her to educate other women. She was joined by Salerno and Nancy Brinker, Susan G. Komen founder and chair of global strategy. The week ended with a lunch featuring a talk from singer and songwriter Nikia Hammonds-Blakely, a breast cancer survivor who was diagnosed with the disease when she was 16 years old.

For more information: www.komen.org


Related Content

News | Breast Imaging

July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has ...

Time July 08, 2025
arrow
News | Breast Imaging

June 25, 2025 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time June 25, 2025
arrow
News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
News | Mammography

Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...

Time December 05, 2024
arrow
Subscribe Now